サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1738162

分子生物学用酵素、キット、試薬の世界市場 2025-2029

Global Molecular Biology Enzymes, Kits, and Reagents Market 2025-2029

出版日
発行
TechNavio
ページ情報
英文 232 Pages
納期
即納可能 即納可能とは
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.76円
分子生物学用酵素、キット、試薬の世界市場 2025-2029
出版日: 2025年05月21日
発行: TechNavio
ページ情報: 英文 232 Pages
納期: 即納可能 即納可能とは
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

分子生物学用酵素、キット、試薬市場は2024-2029年に105億6,090万米ドル、予測期間中のCAGRは9.5%で成長すると予測されます。

当レポートでは、分子生物学用酵素、キット、試薬市場の全体的な分析、市場規模・予測、動向、成長促進要因、課題、約25のベンダーを網羅したベンダー分析などを掲載しています。

現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。遺伝子疾患や慢性疾患の有病率の上昇、資金調達と投資の増加、個別化医療の成長などが市場を牽引しています。

市場範囲
基準年 2025
終了年 2029
予測期間 2025-2029
成長モメンタム 加速
前年比 8.8%
CAGR 9.5%
増分額 105億6,090万米ドル

本調査は、業界の主要参加者からのインプットを含め、一次情報と二次情報を客観的に組み合わせて実施しました。レポートには、主要企業の分析に加え、包括的な市場規模データ、地域別分析によるセグメント、ベンダー情勢が含まれています。レポートには履歴データと予測データがあります。

本調査では、自動化と高スループット技術の統合が、今後数年間の分子生物学用酵素、キット、試薬市場の成長を促進する主要な理由の1つであると特定しています。また、次世代シーケンシングの拡大やM&Aの増加は、市場の大きな需要につながります。

目次

第1章 エグゼクティブサマリー

  • 市場概要

第2章 Technavio分析

  • 価格・ライフサイクル・顧客購入バスケット・採用率・購入基準の分析
  • インプットの重要性と差別化の要因
  • 混乱の要因
  • 促進要因と課題の影響

第3章 市場情勢

  • 市場エコシステム
  • 市場の特徴
  • バリューチェーン分析

第4章 市場規模

  • 市場の定義
  • 市場セグメント分析
  • 市場規模 2024
  • 市場の見通し 2024-2029

第5章 市場規模実績

  • 分子生物学用酵素、キット、試薬の世界市場 2019-2023
  • 製品セグメント分析 2019-2023
  • 用途別セグメント分析 2019-2023
  • エンドユーザーセグメント分析 2019-2023
  • 地域別セグメント分析 2019-2023
  • 国別セグメント分析 2019-2023

第6章 定性分析

  • 米国関税の影響分析：分子生物学用酵素、キット、試薬の世界市場

第7章 ファイブフォース分析

  • ファイブフォースの要約
  • 買い手の交渉力
  • 供給企業の交渉力
  • 新規参入業者の脅威
  • 代替品の脅威
  • 競争の脅威
  • 市況

第8章 市場セグメンテーション：製品別

  • 市場セグメント
  • 比較：製品別
  • キットと試薬：市場規模と予測 2024-2029
  • 酵素：市場規模と予測 2024-2029
  • 市場機会：製品別

第9章 市場セグメンテーション：用途別

  • 市場セグメント
  • 比較：用途別
  • シーケンシング：市場規模と予測 2024-2029
  • PCR：市場規模と予測 2024-2029
  • エピジェネティック：市場規模と予測 2024-2029
  • クローン：市場規模と予測 2024-2029
  • その他：市場規模と予測 2024-2029
  • 市場機会：用途別

第10章 市場セグメンテーション：エンドユーザー別

  • 市場セグメント
  • 比較：エンドユーザー別
  • バイオテクノロジーおよび製薬会社：市場規模と予測 2024-2029
  • 調査・学術機関：市場規模と予測 2024-2029
  • 病院および診断センター：市場規模と予測 2024-2029
  • 市場機会：エンドユーザー別

第11章 顧客情勢

  • 顧客情勢の概要

第12章 地域別情勢

  • 地域別セグメンテーション
  • 地域別比較
  • 北米：市場規模と予測 2024-2029
  • 欧州：市場規模と予測 2024-2029
  • アジア：市場規模と予測 2024-2029
  • 世界のその他の地域：市場規模と予測 2024-2029
  • 米国：市場規模と予測 2024-2029
  • 中国：市場規模と予測 2024-2029
  • ドイツ：市場規模と予測 2024-2029
  • インド：市場規模と予測 2024-2029
  • 英国：市場規模と予測 2024-2029
  • カナダ：市場規模と予測 2024-2029
  • フランス：市場規模と予測 2024-2029
  • 日本：市場規模と予測 2024-2029
  • ブラジル：市場規模と予測 2024-2029
  • 韓国：市場規模と予測 2024-2029
  • 市場機会：地域情勢別

第13章 促進要因・課題・機会・抑制要因

  • 市場促進要因
  • 市場の課題
  • 促進要因と課題の影響
  • 市場の機会・抑制要因

第14章 競合情勢

  • 概要
  • 競合情勢
  • 混乱の状況
  • 業界のリスク

第15章 競合分析

  • 企業プロファイル
  • 企業ランキング指数
  • 企業の市場ポジショニング
  • Agilent Technologies Inc.
  • Bio Rad Laboratories Inc.
  • Bio Techne Corp.
  • Danaher Corp.
  • F. Hoffmann La Roche Ltd.
  • Illumina Inc.
  • Intact Genomics Inc
  • LGC Science Group Holdings Ltd.
  • Lonza Group Ltd.
  • Merck KGaA
  • New England Biolabs Inc.
  • Promega Corp.
  • Sartorius AG
  • Takara Bio Inc.
  • Thermo Fisher Scientific Inc.

第16章 付録

図表

Exhibits:

  • Exhibits1: Executive Summary - Chart on Market Overview
  • Exhibits2: Executive Summary - Data Table on Market Overview
  • Exhibits3: Executive Summary - Chart on Global Market Characteristics
  • Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibits5: Executive Summary - Chart on Market Segmentation by Product
  • Exhibits6: Executive Summary - Chart on Market Segmentation by Application
  • Exhibits7: Executive Summary - Chart on Market Segmentation by End-user
  • Exhibits8: Executive Summary - Chart on Incremental Growth
  • Exhibits9: Executive Summary - Data Table on Incremental Growth
  • Exhibits10: Executive Summary - Chart on Company Market Positioning
  • Exhibits11: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Exhibits12: Overview on criticality of inputs and factors of differentiation
  • Exhibits13: Overview on factors of disruption
  • Exhibits14: Impact of drivers and challenges in 2024 and 2029
  • Exhibits15: Parent Market
  • Exhibits16: Data Table on - Parent Market
  • Exhibits17: Market characteristics analysis
  • Exhibits18: Value chain analysis
  • Exhibits19: Offerings of companies included in the market definition
  • Exhibits20: Market segments
  • Exhibits21: Chart on Global - Market size and forecast 2024-2029 ($ million)
  • Exhibits22: Data Table on Global - Market size and forecast 2024-2029 ($ million)
  • Exhibits23: Chart on Global Market: Year-over-year growth 2024-2029 (%)
  • Exhibits24: Data Table on Global Market: Year-over-year growth 2024-2029 (%)
  • Exhibits25: Historic Market Size - Data Table on Global Molecular Biology Enzymes, Kits, And Reagents Market 2019 - 2023 ($ million)
  • Exhibits26: Historic Market Size - Product Segment 2019 - 2023 ($ million)
  • Exhibits27: Historic Market Size - Application Segment 2019 - 2023 ($ million)
  • Exhibits28: Historic Market Size - End-user Segment 2019 - 2023 ($ million)
  • Exhibits29: Historic Market Size - Geography Segment 2019 - 2023 ($ million)
  • Exhibits30: Historic Market Size - Country Segment 2019 - 2023 ($ million)
  • Exhibits31: Five forces analysis - Comparison between 2024 and 2029
  • Exhibits32: Bargaining power of buyers - Impact of key factors 2024 and 2029
  • Exhibits33: Bargaining power of suppliers - Impact of key factors in 2024 and 2029
  • Exhibits34: Threat of new entrants - Impact of key factors in 2024 and 2029
  • Exhibits35: Threat of substitutes - Impact of key factors in 2024 and 2029
  • Exhibits36: Threat of rivalry - Impact of key factors in 2024 and 2029
  • Exhibits37: Chart on Market condition - Five forces 2024 and 2029
  • Exhibits38: Chart on Product - Market share 2024-2029 (%)
  • Exhibits39: Data Table on Product - Market share 2024-2029 (%)
  • Exhibits40: Chart on Comparison by Product
  • Exhibits41: Data Table on Comparison by Product
  • Exhibits42: Chart on Kits and reagents - Market size and forecast 2024-2029 ($ million)
  • Exhibits43: Data Table on Kits and reagents - Market size and forecast 2024-2029 ($ million)
  • Exhibits44: Chart on Kits and reagents - Year-over-year growth 2024-2029 (%)
  • Exhibits45: Data Table on Kits and reagents - Year-over-year growth 2024-2029 (%)
  • Exhibits46: Chart on Enzymes - Market size and forecast 2024-2029 ($ million)
  • Exhibits47: Data Table on Enzymes - Market size and forecast 2024-2029 ($ million)
  • Exhibits48: Chart on Enzymes - Year-over-year growth 2024-2029 (%)
  • Exhibits49: Data Table on Enzymes - Year-over-year growth 2024-2029 (%)
  • Exhibits50: Market opportunity by Product ($ million)
  • Exhibits51: Data Table on Market opportunity by Product ($ million)
  • Exhibits52: Chart on Application - Market share 2024-2029 (%)
  • Exhibits53: Data Table on Application - Market share 2024-2029 (%)
  • Exhibits54: Chart on Comparison by Application
  • Exhibits55: Data Table on Comparison by Application
  • Exhibits56: Chart on Sequencing - Market size and forecast 2024-2029 ($ million)
  • Exhibits57: Data Table on Sequencing - Market size and forecast 2024-2029 ($ million)
  • Exhibits58: Chart on Sequencing - Year-over-year growth 2024-2029 (%)
  • Exhibits59: Data Table on Sequencing - Year-over-year growth 2024-2029 (%)
  • Exhibits60: Chart on PCR - Market size and forecast 2024-2029 ($ million)
  • Exhibits61: Data Table on PCR - Market size and forecast 2024-2029 ($ million)
  • Exhibits62: Chart on PCR - Year-over-year growth 2024-2029 (%)
  • Exhibits63: Data Table on PCR - Year-over-year growth 2024-2029 (%)
  • Exhibits64: Chart on Epigenetic - Market size and forecast 2024-2029 ($ million)
  • Exhibits65: Data Table on Epigenetic - Market size and forecast 2024-2029 ($ million)
  • Exhibits66: Chart on Epigenetic - Year-over-year growth 2024-2029 (%)
  • Exhibits67: Data Table on Epigenetic - Year-over-year growth 2024-2029 (%)
  • Exhibits68: Chart on Cloning - Market size and forecast 2024-2029 ($ million)
  • Exhibits69: Data Table on Cloning - Market size and forecast 2024-2029 ($ million)
  • Exhibits70: Chart on Cloning - Year-over-year growth 2024-2029 (%)
  • Exhibits71: Data Table on Cloning - Year-over-year growth 2024-2029 (%)
  • Exhibits72: Chart on Others - Market size and forecast 2024-2029 ($ million)
  • Exhibits73: Data Table on Others - Market size and forecast 2024-2029 ($ million)
  • Exhibits74: Chart on Others - Year-over-year growth 2024-2029 (%)
  • Exhibits75: Data Table on Others - Year-over-year growth 2024-2029 (%)
  • Exhibits76: Market opportunity by Application ($ million)
  • Exhibits77: Data Table on Market opportunity by Application ($ million)
  • Exhibits78: Chart on End-user - Market share 2024-2029 (%)
  • Exhibits79: Data Table on End-user - Market share 2024-2029 (%)
  • Exhibits80: Chart on Comparison by End-user
  • Exhibits81: Data Table on Comparison by End-user
  • Exhibits82: Chart on Biotech and pharma companies - Market size and forecast 2024-2029 ($ million)
  • Exhibits83: Data Table on Biotech and pharma companies - Market size and forecast 2024-2029 ($ million)
  • Exhibits84: Chart on Biotech and pharma companies - Year-over-year growth 2024-2029 (%)
  • Exhibits85: Data Table on Biotech and pharma companies - Year-over-year growth 2024-2029 (%)
  • Exhibits86: Chart on Research and academic institutes - Market size and forecast 2024-2029 ($ million)
  • Exhibits87: Data Table on Research and academic institutes - Market size and forecast 2024-2029 ($ million)
  • Exhibits88: Chart on Research and academic institutes - Year-over-year growth 2024-2029 (%)
  • Exhibits89: Data Table on Research and academic institutes - Year-over-year growth 2024-2029 (%)
  • Exhibits90: Chart on Hospitals and diagnostic centers - Market size and forecast 2024-2029 ($ million)
  • Exhibits91: Data Table on Hospitals and diagnostic centers - Market size and forecast 2024-2029 ($ million)
  • Exhibits92: Chart on Hospitals and diagnostic centers - Year-over-year growth 2024-2029 (%)
  • Exhibits93: Data Table on Hospitals and diagnostic centers - Year-over-year growth 2024-2029 (%)
  • Exhibits94: Market opportunity by End-user ($ million)
  • Exhibits95: Data Table on Market opportunity by End-user ($ million)
  • Exhibits96: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Exhibits97: Chart on Market share By Geographical Landscape 2024-2029 (%)
  • Exhibits98: Data Table on Market share By Geographical Landscape 2024-2029 (%)
  • Exhibits99: Chart on Geographic comparison
  • Exhibits100: Data Table on Geographic comparison
  • Exhibits101: Chart on North America - Market size and forecast 2024-2029 ($ million)
  • Exhibits102: Data Table on North America - Market size and forecast 2024-2029 ($ million)
  • Exhibits103: Chart on North America - Year-over-year growth 2024-2029 (%)
  • Exhibits104: Data Table on North America - Year-over-year growth 2024-2029 (%)
  • Exhibits105: Chart on Europe - Market size and forecast 2024-2029 ($ million)
  • Exhibits106: Data Table on Europe - Market size and forecast 2024-2029 ($ million)
  • Exhibits107: Chart on Europe - Year-over-year growth 2024-2029 (%)
  • Exhibits108: Data Table on Europe - Year-over-year growth 2024-2029 (%)
  • Exhibits109: Chart on Asia - Market size and forecast 2024-2029 ($ million)
  • Exhibits110: Data Table on Asia - Market size and forecast 2024-2029 ($ million)
  • Exhibits111: Chart on Asia - Year-over-year growth 2024-2029 (%)
  • Exhibits112: Data Table on Asia - Year-over-year growth 2024-2029 (%)
  • Exhibits113: Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
  • Exhibits114: Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
  • Exhibits115: Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
  • Exhibits116: Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
  • Exhibits117: Chart on US - Market size and forecast 2024-2029 ($ million)
  • Exhibits118: Data Table on US - Market size and forecast 2024-2029 ($ million)
  • Exhibits119: Chart on US - Year-over-year growth 2024-2029 (%)
  • Exhibits120: Data Table on US - Year-over-year growth 2024-2029 (%)
  • Exhibits121: Chart on China - Market size and forecast 2024-2029 ($ million)
  • Exhibits122: Data Table on China - Market size and forecast 2024-2029 ($ million)
  • Exhibits123: Chart on China - Year-over-year growth 2024-2029 (%)
  • Exhibits124: Data Table on China - Year-over-year growth 2024-2029 (%)
  • Exhibits125: Chart on Germany - Market size and forecast 2024-2029 ($ million)
  • Exhibits126: Data Table on Germany - Market size and forecast 2024-2029 ($ million)
  • Exhibits127: Chart on Germany - Year-over-year growth 2024-2029 (%)
  • Exhibits128: Data Table on Germany - Year-over-year growth 2024-2029 (%)
  • Exhibits129: Chart on India - Market size and forecast 2024-2029 ($ million)
  • Exhibits130: Data Table on India - Market size and forecast 2024-2029 ($ million)
  • Exhibits131: Chart on India - Year-over-year growth 2024-2029 (%)
  • Exhibits132: Data Table on India - Year-over-year growth 2024-2029 (%)
  • Exhibits133: Chart on UK - Market size and forecast 2024-2029 ($ million)
  • Exhibits134: Data Table on UK - Market size and forecast 2024-2029 ($ million)
  • Exhibits135: Chart on UK - Year-over-year growth 2024-2029 (%)
  • Exhibits136: Data Table on UK - Year-over-year growth 2024-2029 (%)
  • Exhibits137: Chart on Canada - Market size and forecast 2024-2029 ($ million)
  • Exhibits138: Data Table on Canada - Market size and forecast 2024-2029 ($ million)
  • Exhibits139: Chart on Canada - Year-over-year growth 2024-2029 (%)
  • Exhibits140: Data Table on Canada - Year-over-year growth 2024-2029 (%)
  • Exhibits141: Chart on France - Market size and forecast 2024-2029 ($ million)
  • Exhibits142: Data Table on France - Market size and forecast 2024-2029 ($ million)
  • Exhibits143: Chart on France - Year-over-year growth 2024-2029 (%)
  • Exhibits144: Data Table on France - Year-over-year growth 2024-2029 (%)
  • Exhibits145: Chart on Japan - Market size and forecast 2024-2029 ($ million)
  • Exhibits146: Data Table on Japan - Market size and forecast 2024-2029 ($ million)
  • Exhibits147: Chart on Japan - Year-over-year growth 2024-2029 (%)
  • Exhibits148: Data Table on Japan - Year-over-year growth 2024-2029 (%)
  • Exhibits149: Chart on Brazil - Market size and forecast 2024-2029 ($ million)
  • Exhibits150: Data Table on Brazil - Market size and forecast 2024-2029 ($ million)
  • Exhibits151: Chart on Brazil - Year-over-year growth 2024-2029 (%)
  • Exhibits152: Data Table on Brazil - Year-over-year growth 2024-2029 (%)
  • Exhibits153: Chart on South Korea - Market size and forecast 2024-2029 ($ million)
  • Exhibits154: Data Table on South Korea - Market size and forecast 2024-2029 ($ million)
  • Exhibits155: Chart on South Korea - Year-over-year growth 2024-2029 (%)
  • Exhibits156: Data Table on South Korea - Year-over-year growth 2024-2029 (%)
  • Exhibits157: Market opportunity By Geographical Landscape ($ million)
  • Exhibits158: Data Tables on Market opportunity By Geographical Landscape ($ million)
  • Exhibits159: Impact of drivers and challenges in 2024 and 2029
  • Exhibits160: Overview on criticality of inputs and factors of differentiation
  • Exhibits161: Overview on factors of disruption
  • Exhibits162: Impact of key risks on business
  • Exhibits163: Companies covered
  • Exhibits164: Company ranking index
  • Exhibits165: Matrix on companies position and classification
  • Exhibits166: Agilent Technologies Inc. - Overview
  • Exhibits167: Agilent Technologies Inc. - Business segments
  • Exhibits168: Agilent Technologies Inc. - Key news
  • Exhibits169: Agilent Technologies Inc. - Key offerings
  • Exhibits170: Agilent Technologies Inc. - Segment focus
  • Exhibits171: SWOT
  • Exhibits172: Bio Rad Laboratories Inc. - Overview
  • Exhibits173: Bio Rad Laboratories Inc. - Business segments
  • Exhibits174: Bio Rad Laboratories Inc. - Key news
  • Exhibits175: Bio Rad Laboratories Inc. - Key offerings
  • Exhibits176: Bio Rad Laboratories Inc. - Segment focus
  • Exhibits177: SWOT
  • Exhibits178: Bio Techne Corp. - Overview
  • Exhibits179: Bio Techne Corp. - Business segments
  • Exhibits180: Bio Techne Corp. - Key news
  • Exhibits181: Bio Techne Corp. - Key offerings
  • Exhibits182: Bio Techne Corp. - Segment focus
  • Exhibits183: SWOT
  • Exhibits184: Danaher Corp. - Overview
  • Exhibits185: Danaher Corp. - Business segments
  • Exhibits186: Danaher Corp. - Key news
  • Exhibits187: Danaher Corp. - Key offerings
  • Exhibits188: Danaher Corp. - Segment focus
  • Exhibits189: SWOT
  • Exhibits190: F. Hoffmann La Roche Ltd. - Overview
  • Exhibits191: F. Hoffmann La Roche Ltd. - Business segments
  • Exhibits192: F. Hoffmann La Roche Ltd. - Key news
  • Exhibits193: F. Hoffmann La Roche Ltd. - Key offerings
  • Exhibits194: F. Hoffmann La Roche Ltd. - Segment focus
  • Exhibits195: SWOT
  • Exhibits196: Illumina Inc. - Overview
  • Exhibits197: Illumina Inc. - Business segments
  • Exhibits198: Illumina Inc. - Key news
  • Exhibits199: Illumina Inc. - Key offerings
  • Exhibits200: Illumina Inc. - Segment focus
  • Exhibits201: SWOT
  • Exhibits202: Intact Genomics Inc - Overview
  • Exhibits203: Intact Genomics Inc - Product / Service
  • Exhibits204: Intact Genomics Inc - Key offerings
  • Exhibits205: SWOT
  • Exhibits206: LGC Science Group Holdings Ltd. - Overview
  • Exhibits207: LGC Science Group Holdings Ltd. - Product / Service
  • Exhibits208: LGC Science Group Holdings Ltd. - Key offerings
  • Exhibits209: SWOT
  • Exhibits210: Lonza Group Ltd. - Overview
  • Exhibits211: Lonza Group Ltd. - Business segments
  • Exhibits212: Lonza Group Ltd. - Key news
  • Exhibits213: Lonza Group Ltd. - Key offerings
  • Exhibits214: Lonza Group Ltd. - Segment focus
  • Exhibits215: SWOT
  • Exhibits216: Merck KGaA - Overview
  • Exhibits217: Merck KGaA - Business segments
  • Exhibits218: Merck KGaA - Key news
  • Exhibits219: Merck KGaA - Key offerings
  • Exhibits220: Merck KGaA - Segment focus
  • Exhibits221: SWOT
  • Exhibits222: New England Biolabs Inc. - Overview
  • Exhibits223: New England Biolabs Inc. - Product / Service
  • Exhibits224: New England Biolabs Inc. - Key offerings
  • Exhibits225: SWOT
  • Exhibits226: Promega Corp. - Overview
  • Exhibits227: Promega Corp. - Product / Service
  • Exhibits228: Promega Corp. - Key offerings
  • Exhibits229: SWOT
  • Exhibits230: Sartorius AG - Overview
  • Exhibits231: Sartorius AG - Business segments
  • Exhibits232: Sartorius AG - Key news
  • Exhibits233: Sartorius AG - Key offerings
  • Exhibits234: Sartorius AG - Segment focus
  • Exhibits235: SWOT
  • Exhibits236: Takara Bio Inc. - Overview
  • Exhibits237: Takara Bio Inc. - Product / Service
  • Exhibits238: Takara Bio Inc. - Key offerings
  • Exhibits239: SWOT
  • Exhibits240: Thermo Fisher Scientific Inc. - Overview
  • Exhibits241: Thermo Fisher Scientific Inc. - Business segments
  • Exhibits242: Thermo Fisher Scientific Inc. - Key news
  • Exhibits243: Thermo Fisher Scientific Inc. - Key offerings
  • Exhibits244: Thermo Fisher Scientific Inc. - Segment focus
  • Exhibits245: SWOT
  • Exhibits246: Inclusions checklist
  • Exhibits247: Exclusions checklist
  • Exhibits248: Currency conversion rates for US$
  • Exhibits249: Research methodology
  • Exhibits250: Information sources
  • Exhibits251: Data validation
  • Exhibits252: Validation techniques employed for market sizing
  • Exhibits253: Data synthesis
  • Exhibits254: 360 degree market analysis
  • Exhibits255: List of abbreviations
目次
Product Code: IRTNTR71334

The molecular biology enzymes, kits, and reagents market is forecasted to grow by USD 10,560.9 mn during 2024-2029, accelerating at a CAGR of 9.5% during the forecast period. The report on the molecular biology enzymes, kits, and reagents market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising prevalence of genetic and chronic diseases, increasing funding and investment, and growth of personalized medicine.

Market Scope
Base Year2025
End Year2029
Series Year2025-2029
Growth MomentumAccelerate
YOY 20258.8%
CAGR9.5%
Incremental Value$10,560.9 mn

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's molecular biology enzymes, kits, and reagents market is segmented as below:

By Product

    • Kits and reagents
    • Enzymes

By Application

    • Sequencing
    • PCR
    • Epigenetic
    • Cloning
    • Others

By End-user

    • Biotech and pharma companies
    • Research and academic institutes
    • Hospitals and diagnostic centers

By Geographical Landscape

    • North America
    • Europe
    • Asia
    • Rest of World (ROW)

This study identifies the integration of automation and high-throughput technologies as one of the prime reasons driving the molecular biology enzymes, kits, and reagents market growth during the next few years. Also, expansion of next-generation sequencing and increasing number of mergers and acquisitions will lead to sizable demand in the market.

The report on the molecular biology enzymes, kits, and reagents market covers the following areas:

    • Molecular Biology Enzymes, Kits, And Reagents Market sizing
    • Molecular Biology Enzymes, Kits, And Reagents Market forecast
    • Molecular Biology Enzymes, Kits, And Reagents Market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading molecular biology enzymes, kits, and reagents market vendors that include Agilent Technologies Inc., altona Diagnostics GmbH, Bio Rad Laboratories Inc., Bio Techne Corp., BioEcho Life Sciences GmbH, Cipla Inc., Danaher Corp., F. Hoffmann La Roche Ltd., Genes2Me Pvt. Ltd., HiMedia Laboratories, Illumina Inc., Intact Genomics Inc, LGC Science Group Holdings Ltd., Lonza Group Ltd., Merck KGaA, New England Biolabs Inc., Promega Corp., Sartorius AG, Takara Bio Inc., and Thermo Fisher Scientific Inc.. Also, the molecular biology enzymes, kits, and reagents market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

  • 1.1 Market overview
    • Executive Summary - Chart on Market Overview
    • Executive Summary - Data Table on Market Overview
    • Executive Summary - Chart on Global Market Characteristics
    • Executive Summary - Chart on Market By Geographical Landscape
    • Executive Summary - Chart on Market Segmentation by Product
    • Executive Summary - Chart on Market Segmentation by Application
    • Executive Summary - Chart on Market Segmentation by End-user
    • Executive Summary - Chart on Incremental Growth
    • Executive Summary - Data Table on Incremental Growth
    • Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

  • 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
    • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • 2.2 Criticality of inputs and Factors of differentiation
    • Overview on criticality of inputs and factors of differentiation
  • 2.3 Factors of disruption
    • Overview on factors of disruption
  • 2.4 Impact of drivers and challenges
    • Impact of drivers and challenges in 2024 and 2029

3 Market Landscape

  • 3.1 Market ecosystem
    • Parent Market
    • Data Table on - Parent Market
  • 3.2 Market characteristics
    • Market characteristics analysis
  • 3.3 Value chain analysis
    • Value chain analysis

4 Market Sizing

  • 4.1 Market definition
    • Offerings of companies included in the market definition
  • 4.2 Market segment analysis
    • Market segments
  • 4.3 Market size 2024
  • 4.4 Market outlook: Forecast for 2024-2029
    • Chart on Global - Market size and forecast 2024-2029 ($ million)
    • Data Table on Global - Market size and forecast 2024-2029 ($ million)
    • Chart on Global Market: Year-over-year growth 2024-2029 (%)
    • Data Table on Global Market: Year-over-year growth 2024-2029 (%)

5 Historic Market Size

  • 5.1 Global Molecular Biology Enzymes, Kits, And Reagents Market 2019 - 2023
    • Historic Market Size - Data Table on Global Molecular Biology Enzymes, Kits, And Reagents Market 2019 - 2023 ($ million)
  • 5.2 Product segment analysis 2019 - 2023
    • Historic Market Size - Product Segment 2019 - 2023 ($ million)
  • 5.3 Application segment analysis 2019 - 2023
    • Historic Market Size - Application Segment 2019 - 2023 ($ million)
  • 5.4 End-user segment analysis 2019 - 2023
    • Historic Market Size - End-user Segment 2019 - 2023 ($ million)
  • 5.5 Geography segment analysis 2019 - 2023
    • Historic Market Size - Geography Segment 2019 - 2023 ($ million)
  • 5.6 Country segment analysis 2019 - 2023
    • Historic Market Size - Country Segment 2019 - 2023 ($ million)

6 Qualitative Analysis

  • 6.1 Impact Analysis of U.S. Tariffs on Global Molecular Biology Enzymes, Kits, and Reagents Market

7 Five Forces Analysis

  • 7.1 Five forces summary
    • Five forces analysis - Comparison between 2024 and 2029
  • 7.2 Bargaining power of buyers
    • Bargaining power of buyers - Impact of key factors 2024 and 2029
  • 7.3 Bargaining power of suppliers
    • Bargaining power of suppliers - Impact of key factors in 2024 and 2029
  • 7.4 Threat of new entrants
    • Threat of new entrants - Impact of key factors in 2024 and 2029
  • 7.5 Threat of substitutes
    • Threat of substitutes - Impact of key factors in 2024 and 2029
  • 7.6 Threat of rivalry
    • Threat of rivalry - Impact of key factors in 2024 and 2029
  • 7.7 Market condition
    • Chart on Market condition - Five forces 2024 and 2029

8 Market Segmentation by Product

  • 8.1 Market segments
    • Chart on Product - Market share 2024-2029 (%)
    • Data Table on Product - Market share 2024-2029 (%)
  • 8.2 Comparison by Product
    • Chart on Comparison by Product
    • Data Table on Comparison by Product
  • 8.3 Kits and reagents - Market size and forecast 2024-2029
    • Chart on Kits and reagents - Market size and forecast 2024-2029 ($ million)
    • Data Table on Kits and reagents - Market size and forecast 2024-2029 ($ million)
    • Chart on Kits and reagents - Year-over-year growth 2024-2029 (%)
    • Data Table on Kits and reagents - Year-over-year growth 2024-2029 (%)
  • 8.4 Enzymes - Market size and forecast 2024-2029
    • Chart on Enzymes - Market size and forecast 2024-2029 ($ million)
    • Data Table on Enzymes - Market size and forecast 2024-2029 ($ million)
    • Chart on Enzymes - Year-over-year growth 2024-2029 (%)
    • Data Table on Enzymes - Year-over-year growth 2024-2029 (%)
  • 8.5 Market opportunity by Product
    • Market opportunity by Product ($ million)
    • Data Table on Market opportunity by Product ($ million)

9 Market Segmentation by Application

  • 9.1 Market segments
    • Chart on Application - Market share 2024-2029 (%)
    • Data Table on Application - Market share 2024-2029 (%)
  • 9.2 Comparison by Application
    • Chart on Comparison by Application
    • Data Table on Comparison by Application
  • 9.3 Sequencing - Market size and forecast 2024-2029
    • Chart on Sequencing - Market size and forecast 2024-2029 ($ million)
    • Data Table on Sequencing - Market size and forecast 2024-2029 ($ million)
    • Chart on Sequencing - Year-over-year growth 2024-2029 (%)
    • Data Table on Sequencing - Year-over-year growth 2024-2029 (%)
  • 9.4 PCR - Market size and forecast 2024-2029
    • Chart on PCR - Market size and forecast 2024-2029 ($ million)
    • Data Table on PCR - Market size and forecast 2024-2029 ($ million)
    • Chart on PCR - Year-over-year growth 2024-2029 (%)
    • Data Table on PCR - Year-over-year growth 2024-2029 (%)
  • 9.5 Epigenetic - Market size and forecast 2024-2029
    • Chart on Epigenetic - Market size and forecast 2024-2029 ($ million)
    • Data Table on Epigenetic - Market size and forecast 2024-2029 ($ million)
    • Chart on Epigenetic - Year-over-year growth 2024-2029 (%)
    • Data Table on Epigenetic - Year-over-year growth 2024-2029 (%)
  • 9.6 Cloning - Market size and forecast 2024-2029
    • Chart on Cloning - Market size and forecast 2024-2029 ($ million)
    • Data Table on Cloning - Market size and forecast 2024-2029 ($ million)
    • Chart on Cloning - Year-over-year growth 2024-2029 (%)
    • Data Table on Cloning - Year-over-year growth 2024-2029 (%)
  • 9.7 Others - Market size and forecast 2024-2029
    • Chart on Others - Market size and forecast 2024-2029 ($ million)
    • Data Table on Others - Market size and forecast 2024-2029 ($ million)
    • Chart on Others - Year-over-year growth 2024-2029 (%)
    • Data Table on Others - Year-over-year growth 2024-2029 (%)
  • 9.8 Market opportunity by Application
    • Market opportunity by Application ($ million)
    • Data Table on Market opportunity by Application ($ million)

10 Market Segmentation by End-user

  • 10.1 Market segments
    • Chart on End-user - Market share 2024-2029 (%)
    • Data Table on End-user - Market share 2024-2029 (%)
  • 10.2 Comparison by End-user
    • Chart on Comparison by End-user
    • Data Table on Comparison by End-user
  • 10.3 Biotech and pharma companies - Market size and forecast 2024-2029
    • Chart on Biotech and pharma companies - Market size and forecast 2024-2029 ($ million)
    • Data Table on Biotech and pharma companies - Market size and forecast 2024-2029 ($ million)
    • Chart on Biotech and pharma companies - Year-over-year growth 2024-2029 (%)
    • Data Table on Biotech and pharma companies - Year-over-year growth 2024-2029 (%)
  • 10.4 Research and academic institutes - Market size and forecast 2024-2029
    • Chart on Research and academic institutes - Market size and forecast 2024-2029 ($ million)
    • Data Table on Research and academic institutes - Market size and forecast 2024-2029 ($ million)
    • Chart on Research and academic institutes - Year-over-year growth 2024-2029 (%)
    • Data Table on Research and academic institutes - Year-over-year growth 2024-2029 (%)
  • 10.5 Hospitals and diagnostic centers - Market size and forecast 2024-2029
    • Chart on Hospitals and diagnostic centers - Market size and forecast 2024-2029 ($ million)
    • Data Table on Hospitals and diagnostic centers - Market size and forecast 2024-2029 ($ million)
    • Chart on Hospitals and diagnostic centers - Year-over-year growth 2024-2029 (%)
    • Data Table on Hospitals and diagnostic centers - Year-over-year growth 2024-2029 (%)
  • 10.6 Market opportunity by End-user
    • Market opportunity by End-user ($ million)
    • Data Table on Market opportunity by End-user ($ million)

11 Customer Landscape

  • 11.1 Customer landscape overview
    • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Geographic Landscape

  • 12.1 Geographic segmentation
    • Chart on Market share By Geographical Landscape 2024-2029 (%)
    • Data Table on Market share By Geographical Landscape 2024-2029 (%)
  • 12.2 Geographic comparison
    • Chart on Geographic comparison
    • Data Table on Geographic comparison
  • 12.3 North America - Market size and forecast 2024-2029
    • Chart on North America - Market size and forecast 2024-2029 ($ million)
    • Data Table on North America - Market size and forecast 2024-2029 ($ million)
    • Chart on North America - Year-over-year growth 2024-2029 (%)
    • Data Table on North America - Year-over-year growth 2024-2029 (%)
  • 12.4 Europe - Market size and forecast 2024-2029
    • Chart on Europe - Market size and forecast 2024-2029 ($ million)
    • Data Table on Europe - Market size and forecast 2024-2029 ($ million)
    • Chart on Europe - Year-over-year growth 2024-2029 (%)
    • Data Table on Europe - Year-over-year growth 2024-2029 (%)
  • 12.5 Asia - Market size and forecast 2024-2029
    • Chart on Asia - Market size and forecast 2024-2029 ($ million)
    • Data Table on Asia - Market size and forecast 2024-2029 ($ million)
    • Chart on Asia - Year-over-year growth 2024-2029 (%)
    • Data Table on Asia - Year-over-year growth 2024-2029 (%)
  • 12.6 Rest of World (ROW) - Market size and forecast 2024-2029
    • Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
    • Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
    • Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
    • Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
  • 12.7 US - Market size and forecast 2024-2029
    • Chart on US - Market size and forecast 2024-2029 ($ million)
    • Data Table on US - Market size and forecast 2024-2029 ($ million)
    • Chart on US - Year-over-year growth 2024-2029 (%)
    • Data Table on US - Year-over-year growth 2024-2029 (%)
  • 12.8 China - Market size and forecast 2024-2029
    • Chart on China - Market size and forecast 2024-2029 ($ million)
    • Data Table on China - Market size and forecast 2024-2029 ($ million)
    • Chart on China - Year-over-year growth 2024-2029 (%)
    • Data Table on China - Year-over-year growth 2024-2029 (%)
  • 12.9 Germany - Market size and forecast 2024-2029
    • Chart on Germany - Market size and forecast 2024-2029 ($ million)
    • Data Table on Germany - Market size and forecast 2024-2029 ($ million)
    • Chart on Germany - Year-over-year growth 2024-2029 (%)
    • Data Table on Germany - Year-over-year growth 2024-2029 (%)
  • 12.10 India - Market size and forecast 2024-2029
    • Chart on India - Market size and forecast 2024-2029 ($ million)
    • Data Table on India - Market size and forecast 2024-2029 ($ million)
    • Chart on India - Year-over-year growth 2024-2029 (%)
    • Data Table on India - Year-over-year growth 2024-2029 (%)
  • 12.11 UK - Market size and forecast 2024-2029
    • Chart on UK - Market size and forecast 2024-2029 ($ million)
    • Data Table on UK - Market size and forecast 2024-2029 ($ million)
    • Chart on UK - Year-over-year growth 2024-2029 (%)
    • Data Table on UK - Year-over-year growth 2024-2029 (%)
  • 12.12 Canada - Market size and forecast 2024-2029
    • Chart on Canada - Market size and forecast 2024-2029 ($ million)
    • Data Table on Canada - Market size and forecast 2024-2029 ($ million)
    • Chart on Canada - Year-over-year growth 2024-2029 (%)
    • Data Table on Canada - Year-over-year growth 2024-2029 (%)
  • 12.13 France - Market size and forecast 2024-2029
    • Chart on France - Market size and forecast 2024-2029 ($ million)
    • Data Table on France - Market size and forecast 2024-2029 ($ million)
    • Chart on France - Year-over-year growth 2024-2029 (%)
    • Data Table on France - Year-over-year growth 2024-2029 (%)
  • 12.14 Japan - Market size and forecast 2024-2029
    • Chart on Japan - Market size and forecast 2024-2029 ($ million)
    • Data Table on Japan - Market size and forecast 2024-2029 ($ million)
    • Chart on Japan - Year-over-year growth 2024-2029 (%)
    • Data Table on Japan - Year-over-year growth 2024-2029 (%)
  • 12.15 Brazil - Market size and forecast 2024-2029
    • Chart on Brazil - Market size and forecast 2024-2029 ($ million)
    • Data Table on Brazil - Market size and forecast 2024-2029 ($ million)
    • Chart on Brazil - Year-over-year growth 2024-2029 (%)
    • Data Table on Brazil - Year-over-year growth 2024-2029 (%)
  • 12.16 South Korea - Market size and forecast 2024-2029
    • Chart on South Korea - Market size and forecast 2024-2029 ($ million)
    • Data Table on South Korea - Market size and forecast 2024-2029 ($ million)
    • Chart on South Korea - Year-over-year growth 2024-2029 (%)
    • Data Table on South Korea - Year-over-year growth 2024-2029 (%)
  • 12.17 Market opportunity By Geographical Landscape
    • Market opportunity By Geographical Landscape ($ million)
    • Data Tables on Market opportunity By Geographical Landscape ($ million)

13 Drivers, Challenges, and Opportunity/Restraints

  • 13.1 Market drivers
  • 13.2 Market challenges
  • 13.3 Impact of drivers and challenges
    • Impact of drivers and challenges in 2024 and 2029
  • 13.4 Market opportunities/restraints

14 Competitive Landscape

  • 14.1 Overview
  • 14.2 Competitive Landscape
    • Overview on criticality of inputs and factors of differentiation
  • 14.3 Landscape disruption
    • Overview on factors of disruption
  • 14.4 Industry risks
    • Impact of key risks on business

15 Competitive Analysis

  • 15.1 Companies profiled
    • Companies covered
  • 15.2 Company ranking index
    • Company ranking index
  • 15.3 Market positioning of companies
    • Matrix on companies position and classification
  • 15.4 Agilent Technologies Inc.
    • Agilent Technologies Inc. - Overview
    • Agilent Technologies Inc. - Business segments
    • Agilent Technologies Inc. - Key news
    • Agilent Technologies Inc. - Key offerings
    • Agilent Technologies Inc. - Segment focus
    • SWOT
  • 15.5 Bio Rad Laboratories Inc.
    • Bio Rad Laboratories Inc. - Overview
    • Bio Rad Laboratories Inc. - Business segments
    • Bio Rad Laboratories Inc. - Key news
    • Bio Rad Laboratories Inc. - Key offerings
    • Bio Rad Laboratories Inc. - Segment focus
    • SWOT
  • 15.6 Bio Techne Corp.
    • Bio Techne Corp. - Overview
    • Bio Techne Corp. - Business segments
    • Bio Techne Corp. - Key news
    • Bio Techne Corp. - Key offerings
    • Bio Techne Corp. - Segment focus
    • SWOT
  • 15.7 Danaher Corp.
    • Danaher Corp. - Overview
    • Danaher Corp. - Business segments
    • Danaher Corp. - Key news
    • Danaher Corp. - Key offerings
    • Danaher Corp. - Segment focus
    • SWOT
  • 15.8 F. Hoffmann La Roche Ltd.
    • F. Hoffmann La Roche Ltd. - Overview
    • F. Hoffmann La Roche Ltd. - Business segments
    • F. Hoffmann La Roche Ltd. - Key news
    • F. Hoffmann La Roche Ltd. - Key offerings
    • F. Hoffmann La Roche Ltd. - Segment focus
    • SWOT
  • 15.9 Illumina Inc.
    • Illumina Inc. - Overview
    • Illumina Inc. - Business segments
    • Illumina Inc. - Key news
    • Illumina Inc. - Key offerings
    • Illumina Inc. - Segment focus
    • SWOT
  • 15.10 Intact Genomics Inc
    • Intact Genomics Inc - Overview
    • Intact Genomics Inc - Product / Service
    • Intact Genomics Inc - Key offerings
    • SWOT
  • 15.11 LGC Science Group Holdings Ltd.
    • LGC Science Group Holdings Ltd. - Overview
    • LGC Science Group Holdings Ltd. - Product / Service
    • LGC Science Group Holdings Ltd. - Key offerings
    • SWOT
  • 15.12 Lonza Group Ltd.
    • Lonza Group Ltd. - Overview
    • Lonza Group Ltd. - Business segments
    • Lonza Group Ltd. - Key news
    • Lonza Group Ltd. - Key offerings
    • Lonza Group Ltd. - Segment focus
    • SWOT
  • 15.13 Merck KGaA
    • Merck KGaA - Overview
    • Merck KGaA - Business segments
    • Merck KGaA - Key news
    • Merck KGaA - Key offerings
    • Merck KGaA - Segment focus
    • SWOT
  • 15.14 New England Biolabs Inc.
    • New England Biolabs Inc. - Overview
    • New England Biolabs Inc. - Product / Service
    • New England Biolabs Inc. - Key offerings
    • SWOT
  • 15.15 Promega Corp.
    • Promega Corp. - Overview
    • Promega Corp. - Product / Service
    • Promega Corp. - Key offerings
    • SWOT
  • 15.16 Sartorius AG
    • Sartorius AG - Overview
    • Sartorius AG - Business segments
    • Sartorius AG - Key news
    • Sartorius AG - Key offerings
    • Sartorius AG - Segment focus
    • SWOT
  • 15.17 Takara Bio Inc.
    • Takara Bio Inc. - Overview
    • Takara Bio Inc. - Product / Service
    • Takara Bio Inc. - Key offerings
    • SWOT
  • 15.18 Thermo Fisher Scientific Inc.
    • Thermo Fisher Scientific Inc. - Overview
    • Thermo Fisher Scientific Inc. - Business segments
    • Thermo Fisher Scientific Inc. - Key news
    • Thermo Fisher Scientific Inc. - Key offerings
    • Thermo Fisher Scientific Inc. - Segment focus
    • SWOT

16 Appendix

  • 16.1 Scope of the report
  • 16.2 Inclusions and exclusions checklist
    • Inclusions checklist
    • Exclusions checklist
  • 16.3 Currency conversion rates for US$
    • Currency conversion rates for US$
  • 16.4 Research methodology
    • Research methodology
  • 16.5 Data procurement
    • Information sources
  • 16.6 Data validation
    • Data validation
  • 16.7 Validation techniques employed for market sizing
    • Validation techniques employed for market sizing
  • 16.8 Data synthesis
    • Data synthesis
  • 16.9 360 degree market analysis
    • 360 degree market analysis
  • 16.10 List of abbreviations
    • List of abbreviations